美洲獅生物技術有限公司
US ˙ NasdaqGS ˙ US74587V1070

SecurityPBYI / Puma Biotechnology, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership534,227 shares
Latest Disclosed Value $ 3,413,710
UBS Group AG ownership in PBYI / Puma Biotechnology, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 534,227 shares of Puma Biotechnology, Inc. (US:PBYI) valued at $3,413,711 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 127,312 shares of Puma Biotechnology, Inc.. This represents a change in shares of 319.62% during the quarter. The current value of the position is $3,744,931 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PBYI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PBYI / Puma Biotechnology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 534,227 406,915 319.62 3,414 350.86 0.0001
2026-01-29 2025-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 127,312 -248,779 -66.15 758 -62.09 0.0000
2025-11-13 2025-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 376,091 101,991 37.21 1,997 112.45 0.0003
2025-08-14 2025-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 274,100 -5,567 -1.99 940 13.66 0.0002
2025-05-13 2025-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 279,667 124,096 79.77 828 74.47 0.0002
2025-02-14 2024-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 155,571 128,477 474.19 474 586.96 0.0001
2024-11-14 2024-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 27,094 6,767 33.29 69 4.55 0.0000
2024-08-14 2024-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 20,327 9,684 90.99 66 17.86 0.0000
2024-05-13 2024-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 10,643 -480 -4.32 56 16.67 0.0000
2024-02-09 2023-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 11,123 7,717 226.57 48 500.00 0.0000
2023-11-09 2023-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 3,406 -654 -16.11 9 -42.86 0.0000
2023-08-11 2023-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 4,060 -6,865 -62.84 14 -57.58 0.0000
2023-05-12 2023-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 10,925 7,485 217.59 34 135.71 0.0000
2023-02-08 2022-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 3,440 15 0.44 15 75.00 0.0000
2022-11-10 2022-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 3,425 -1,114 -24.54 8 -38.46 0.0000
2022-08-10 2022-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 4,539 -21,446 -82.53 13 -82.67 0.0000
2022-05-16 2022-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 25,985 8,523 48.81 75 41.51 0.0000
2022-02-14 2021-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 17,462 10,938 167.66 53 15.22 0.0000
2021-11-15 2021-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 6,524 -3,761 -36.57 46 -51.06 0.0000
2021-08-13 2021-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 10,285 -47,051 -82.06 94 -83.12 0.0000
2021-05-12 2021-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 57,336 48,048 517.31 557 486.32 0.0002
2021-02-11 2020-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 9,288 -149,670 -94.16 95 -94.08 0.0000
2020-11-12 2020-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 158,958 -531 -0.33 1,604 -3.55 0.0006
2020-07-31 2020-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 159,489 -5,008 -3.04 1,663 19.81 0.0007
2020-05-01 2020-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 164,497 148,324 917.11 1,388 877.46 0.0007
2020-02-14 2019-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 16,173 -222,615 -93.23 142 -94.48 0.0000
2019-11-14 2019-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 238,788 224,627 1,586.24 2,571 1,328.33 0.0010
2019-08-14 2019-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 14,161 -11,158 -44.07 180 -81.67 0.0001
2019-05-14 2019-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 25,319 -166,990 -86.83 982 -74.91 0.0004
2019-02-14 2018-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 192,309 132,663 222.42 3,914 43.11 0.0018
2018-11-14 2018-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 59,646 18,878 46.31 2,735 13.44 0.0011
2018-08-14 2018-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 40,768 -30,683 -42.94 2,411 -50.41 0.0010
2018-05-15 2018-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 71,451 -121,029 -62.88 4,862 -74.45 0.0021
2018-02-14 2017-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 192,480 146,362 317.36 19,027 244.50 0.0078
2017-11-14 2017-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 46,118 -14,008 -23.30 5,523 5.10 0.0026
2017-11-14 2017-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 60,126 -13,658 -18.51 5,255 91.44 0.0027
2017-08-14 2017-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 60,126 -13,658 5,255
2017-11-14 2017-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 73,784 -93,533 -55.90 2,745 -46.56 0.0015
2017-05-12 2017-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 73,784 -93,533 2,745
2017-02-14 2016-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 167,317 53,939 47.57 5,137 -32.43 0.0028
2016-11-14 2016-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 113,378 -28,592 -20.14 7,602 79.76 0.0045
2016-08-12 2016-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 141,970 19,761 16.17 4,229 17.83 0.0027
2016-05-12 2016-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 122,209 22,351 22.38 3,589 -54.16 0.0024
2016-02-16 2015-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 99,858 -65,191 -39.50 7,829 -37.06 0.0051
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 165,049 5,874 3.69 12,438 -33.07 0.0088
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 159,175 39,097 32.56 18,583 -34.45 0.0124
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 120,078 78,890 191.54 28,351 263.71 0.0196
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 41,188 41,188 7,795 0.0054
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COM Call 700 132 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY COM Put 10,400 1,633.33 2,456 2,054.39 n/a n/a n/a
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COM Put 600 114 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.